Sunshine Biopharma Inc.

The momentum for this stock is not very good. Sunshine Biopharma Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Sunshine Biopharma Inc..

News

Sunshine Biopharma announces publication of coronavirus research results

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Accesswire Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18%Development of a novel antiviral compound, XR8-23 (Compound 10), targeting SARS-CoV-2 papain-like protease (PLpro) with both...\n more…

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Accesswire FORT LAUDERDALE, FL / ACCESSWIRE / August 26, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the 'Company'), a pharmaceutical company offering and researching life-saving medicines in a variety of...\n more…

Sunshine Biopharma reports Q2 revenue $9.3M vs. $5.6M last year

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Accesswire FORT LAUDERDALE, FL / ACCESSWIRE / August 19, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the 'Company'), a pharmaceutical company offering and researching life-saving medicines in a variety of...\n more…

Sunshine Biopharma (NASDAQ:SBFM) Posts Quarterly Earnings Results

Ticker Report Sunshine Biopharma (NASDAQ:SBFM - Get Free Report) issued its quarterly earnings results on Friday. The company reported ($9.94) EPS for the quarter, reports. Sunshine Biopharma had a negative return...\n more…